Elutia Inc
ELUT
NASDAQ
Biotechnology
$0.94
USD
+0.08 (+9.38%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $37.54M
Volume 67.0K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
MGX | Metagenomi Therapeutics Inc | $46.31M | - | -50.7% | - | |
CRVO | CervoMed Inc | $45.36M | - | -78.5% | - | |
KPTI | Karyopharm Therapeutics Inc | $45.10M | - | +6.3% | - | |
MCRB | Seres Therapeutics Inc | $44.93M | - | - | - | |
ALGS | Aligos Therapeutics Inc | $42.28M | - | +43.9% | - | |
TVGN | Tevogen Bio Holdings Inc | $42.16M | - | - | - | |
NXTC | NextCure Inc | $38.08M | - | - | - | |
ELUT | Elutia Inc | $37.54M | 0.75 | -32.6% | - |
Top Peer by Growth
Aligos Therapeutics Inc
+43.9% YoY Revenue
Lowest P/E Ratio
Elutia Inc
0.75x P/E
Best 1-Year Return
NextCure Inc
+59.5% Return